Neoadjuvant Therapy with Weekly Nanoparticle Albumin‐Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011‐02), a Multicenter, Non‐Randomized, Phase II Trial, with a Companion Biomarker Analysis

BACKGROUND. Nanoparticle albumin‐bound paclitaxel (nab‐Paclitaxel) is an alternative to standard taxanes for breast cancer (BC) treatment. We evaluated nab‐Paclitaxel efficacy as neoadjuvant treatment for early estrogen receptor‐positive (ER+), human epidermal growth factor receptor 2‐negative (HER2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Martín, Miguel, Chacón, José I., Antón, Antonio, Plazaola, Arrate, García‐Martínez, Elena, Seguí, Miguel A., Sánchez‐Rovira, Pedro, Palacios, José, Calvo, Lourdes, Esteban, Carmen, Espinosa, Enrique, Barnadas, Agusti, Batista, Norberto, Guerrero, Angel, Muñoz, Montserrat, Romio, Estefania, Rodríguez‐Martín, César, Caballero, Rosalía, Casas, María I., Rojo, Federico, Carrasco, Eva, Antolín, Silvia
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2017
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5679821/
https://ncbi.nlm.nih.gov/pubmed/28701571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0052
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados